PERSPECTIVES
Although the focus of INEBRIA is on brief interventions for hazardous and harmful substance use, one of the objectives of the organization is to promote integration of the study of brief interventions within the wider context of measures to prevent and reduce substance-related harm. From this perspective, the issue of industry relations and funding is considerably broader than brief interventions and is applicable to all forms of alcohol research, indeed to all research involving consumption of hazardous products, including dependence-producing substances, unhealthy food, or gambling.
Although membership in INEBRIA will not be contingent on nonreceipt of funds from the alcohol industry, all current members have been invited to endorse the position statement, as will individuals wishing to join INEBRIA in the future. All individuals wishing to present at an INEBRIA meeting will also be required to complete a conflict of interest declaration for the work being presented. Members of the Coordinating Committee will also sign a conflict of interest declaration and may not have worked with or received funding from the alcohol industry, directly or indirectly, in the 5 years before their election date, or during their term of office.
The position statement is based on a report of a working group of members and invited experts who convened to consider these issues in depth. The practical and ethical challenges associated with the acceptance of funding for clinical services and research are becoming increasingly complex in a context where research plays a greater role in the regulation and marketing of potentially addictive products. Since publication of the World Health Organization's Global Strategy to Reduce the Harmful Use of Alcohol (World Health Organization, 2010) , the global alcohol producers have accelerated their corporate social responsibility activities, which in many cases conflict with the research and policy initiatives advocated by public health authorities (Mc-Cambridge et al., 2013) . Such corporate social responsibility activities are used in lobbying for industry-favorable policies, involving less regulation, contrary to evidence-based policies that have a wider population reach. It is reasonable
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that society should define corporations' social responsibilities rather than simply accepting that corporations should do so in their own economic interests. In addition to the potential for bias in the design, conduct, and reporting of research, industry funding for a particular topic may or may not be selected for scientific reasons. To the extent that funding for a particular research question is dictated by commercial reasons, it is likely to alter the research agenda of the recipient organization or an individual .
Although early identification and brief intervention show efficacy on the individual level, there is as yet no evidence that it can achieve a noticeable population-level reduction in per capita consumption or alcohol-related harm unless accompanied by more effective alcohol control measures (Heather, 2012) . Therefore, it is possible that the industry may promote and fund brief intervention activities because they pose little threat to their profits, and this offers an approach with a stronger evidential tradition than other alternative policy measures favored by the industry, such as reliance on public education alone (Babor & Robaina, 2013; Stenius & Babor, 2010) .
Concerns about industry attention to brief interventions were initially raised by industry-funded submissions to present at INEBRIA annual conferences and by an industryfunded program to train every employee assistance clinician in the United States in brief intervention (Diageo, n.d.) . We were also aware of industry using support for brief interventions in its efforts to thwart the evidence-based policy of minimum unit pricing of alcohol in Scotland . There have been wider concerns that the main effects of the alcohol industry's cooperation with scientists and health professionals have been to improve their image with the public and with government policymakers, rather than to promote science (Babor & Robaina, 2013; Global Alcohol Policy Alliance, 2013) .
Several arguments have been advanced against accepting industry funding for such programs. These arguments can be summarized within Peter Adams' (2012) moral jeopardy framework, which is designed to assess a variety of risks involved with accepting funding from dangerous consumption industries. The PERIL framework (Purpose, Extent, Relevant-harm, Identifiers, Link) assesses a variety of risks based on a continuum of moral jeopardy, from minor involvements to major conflicts (Adams, 2007) . INEBRIA finds industry funding or other support for brief intervention activities incompatible with the aims of the organization. We encourage similar consideration of these issues among researchers in other fields, such as the gambling (Livingstone & Adams, 2016) or cannabis (Barry et al., 2014) fields, just to mention two areas of recent rapidly developing consumer interest following technological or policy changes, huge commercial interest, and lack of clear guidelines for researchers.
Consideration of industry funding for alcohol research is complicated by the argument that the industry should take some responsibility for the damage caused by alcohol. However, the amount of financial support and the nature of the programs supported in the area of brief intervention (e.g., time-limited, low-impact pilot programs) amount to a trivial contribution to address the damage caused by alcohol. To the extent that the industry is deriving political benefit and improved public perceptions through these generally minimal contributions, the risks far outweigh the benefits, and any association should be avoided.
Important lessons can be drawn from other fields in which industry-funded research produces industry-favorable results. Drug research sponsored by the pharmaceutical industry is more likely to end up favoring the drug under consideration than are studies sponsored by government grants or charitable organizations (Als-Nielsen et al., 2003) . Similarly, nutrition research sponsored by the food industry is more likely to end up favoring the food under consideration than is independently funded research (Lesser et al., 2007) . Wallace (2009) reported that interpretative bias played a role in the research funded by the tobacco industry claiming a genetic predisposition to lung cancer and that studies tended to overestimate genetic risk. Also, just as the tobacco companies have extensively used philanthropy as a political device (Chapman, 2011; Fooks & Gilmore, 2013; Tesler & Malone, 2008) , there is emerging evidence that the alcohol industry is behaving similarly with the funding of charities Lyness & McCambridge, 2014; Matzopoulos et al., 2012) .
Brief intervention capable of initiating or supporting behavior change is an alluring idea, and the evidence base makes it attractive to scientists tackling other problems, as well as corporate vested interests seeking to influence science and policy, for reasons quite similar to those described here. For example, the gambling industry's National Center for Responsible Gaming has made SBIRT (Screening, Brief Intervention, and Referral to Treatment) a funding priority for 2015 (National Center for Responsible Gaming, 2015) . This indicates that the implications of these issues, and of our handling of them, are much wider and deserving of attention. These issues are also complex and require careful handling and well-considered guidance. We know how useful expert advice has been, and we see much value in sharing our experience with other scientific organizations facing similar issues. We have already begun to do so with ICARA (the International Confederation of ATOD [Alcohol, Tobacco and Other Drug] Research Associations).
We will pay careful attention to further industry efforts to capture the science of brief intervention. For example, we note the recent endowment of a chair at Harvard Medical School in the name of Morris E. Chafetz, the founding father of brief intervention, by an alcohol industry body (with the agreement of the family) (Foundation for Advancing Alcohol Responsibility, 2015) . There is an obvious ethical risk in accepting support from sources that have aims that largely oppose those of the receiving organization. This is the core argument of the INEBRIA position statement. Accepting support from the alcohol industry sends a message that the industry is doing what it can to reduce alcohol-related harm and will inadvertently weaken wider efforts to reduce the damage done to population health and society.
Commentary on INEBRIA's Position Statement on the Alcohol Industry
We strongly support INEBRIA's position on members not accepting funding or support from alcohol industry sources. We see this as important step in preventing brief intervention researchers and professionals from being drawn in to supporting industry objectives in their engagements with policymakers.
The key messages industry players seek to advance with government policy and decision makers are (a) alcoholrelated harm is the result of individual behavior, (b) industry initiatives are effective at reducing harm by promoting responsible drinking by individuals, and, accordingly, (c) there is no need for public health policy interventions.
Projects using the principles of brief intervention are highly attractive to industry because they fit in comfortably with the above messages and focus attention on the individual behavior of risky drinkers, thereby diverting attention away from the products and consuming environments. The industry is then able to profile these efforts and promote the public and highly political message that industry has the problems in hand and effective public health interventions, such as price increases or constraints on availability, are unnecessary.
The position statement also recognizes the variety of ways industry makes its funding available, including through direct funding of projects or indirect funding through industry research bodies, or via social aspects and public relations organizations (SAPROs). We have looked in more detail at how this plays out with gambling in a recent article (Livingstone & Adams, 2016) . Initiatives funded by each of these routes typically turn into public relations exercises with high-profile media exposure of all those involved, as has occurred with many industry-supported health and public health initiatives (Babor & Robaina, 2013; Miller et al., 2011) .
What the position statement does not discuss are situations where funding is channeled through governmentadministered mechanisms such as hypothecated levies on alcohol consumption. In our experience, this alternative indirect form of funding is prone to industry influence and can end up suiting industry interests in much the same way as funding through industry research bodies or SAPROs. The perils associated with hypothecated funding and how it enables industry to influence research initiatives and intervention options are discussed in detail in a recent book by the first author (Adams, 2016) . We acknowledge that this is a common path for funding research in this field, including tobacco and gambling. It is very important to ensure that, if this path is followed, decision-making by such funding mechanisms is entirely independent of industry influence. Otherwise, they risk serving as a Trojan horse for industry interests.
We also wonder about the distinction drawn in the footnote between state-sector and private-sector enterprises and funding. State-owned alcohol enterprises (such as those in parts of Canada and Scandinavia) draw profits equally from people experiencing harm from their drinking and for this reason are motivated to protect profits by shaping policy and regulation. Indeed, the blurring of public and private roles could strengthen the links between industry and policy, as well as improve their capacity to reduce transparency. It may be useful to consider the extent to which public sector operators in this area are required to reduce harm and the extent to which independent oversight occurs in a way that ensures this is a priority for these operators. Unless this can be demonstrated unequivocally, we would be concerned that such operators may well be captured by the same logic that guides the behaviors of private-sector alcohol industry actors.
However, notwithstanding these minor reservations, we applaud the position statement as providing both leadership and improved clarity on this important research issue.
